FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely pharmacy and may be used for creating an oral solid dosage form. The dosage form contains a pharmaceutically acceptable salt of an alkaline-earth metal of 5-methyk-(6S)-tetrahydrofolic acid and granules containing progestogen, oestrogen and microcrystalline cellulose. What is also presented is a pharmaceutical kit for females for providing the concentrations or treating the diseases, conditions or symptoms associated with endogenous oestrogen deficiency.
EFFECT: group of inventions provides the good storage stability of tetrahydrofolic acid, and at the same time provides rapid and reliable release of oestrogen and progestogen being parts of the composition.
13 cl, 3 dwg, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROPHOLIC ACID | 2012 |
|
RU2624236C2 |
| SCHEME OF ESTROGEN REPLENISHMENT | 2003 |
|
RU2340345C2 |
| DROSPIRENONE FOR HORMONAL REPLACEMENT THERAPY | 2005 |
|
RU2402331C2 |
| DROSPYRENON FOR REPLACEMENT HORMONOTHERAPY | 2001 |
|
RU2275198C2 |
| MULTIPHASE PHARMACEUTICAL PREPARATION FOR OVULATION INHIBITION IN MAMMAL | 2005 |
|
RU2396082C2 |
| PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE USES AS CONTRACEPTIVE | 2000 |
|
RU2449796C2 |
| PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING IT AND MULTIPHASE PHARMACEUTICAL PREPARATION FOR OVULATION INHIBITION IN MAMMAL | 2010 |
|
RU2482853C2 |
| PHARMACEUTICAL COMBINATION OF ETHYNYLESTRADIOL AND DROSPIRENONE FOR USING AS CONTRACEPTIVE | 2000 |
|
RU2269342C9 |
| COMPOSITIONS AND A METHOD OF CONCEPTION PREVENTION | 1988 |
|
RU2114621C1 |
| METHOD OF PREPARING DOSING UNITS BY WET GRANULATION METHOD | 1995 |
|
RU2166936C2 |
